Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in Bangladesh

BACKGROUND: Coronavirus disease (COVID)-19 has devasted the healthcare delivery system as well as social establishments of almost all countries of the world. However, vaccines for containing new cases of COVID-19 are yet to be realized. Also, presently available antiviral drugs and other standard of...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Md Azizul, Mazumder, Masudul A, Akhter, Neelima, Huq, AKM Faizul, Al-Mahtab, Mamun, Khan, Md Sakirul I, Akbar, Sheikh MF
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801887/
https://www.ncbi.nlm.nih.gov/pubmed/33511068
http://dx.doi.org/10.5005/jp-journals-10018-1327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801887/
https://www.ncbi.nlm.nih.gov/pubmed/33511068
http://dx.doi.org/10.5005/jp-journals-10018-1327

Ejemplares similares